Medicare Enrolled

Dr. Elizabeth Arena, M.D.

Surgical Oncology Physician · Los Angeles, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
8635 W 3RD ST STE 880W, Los Angeles, CA 90048
2139474938
In practice since 2009 (16 years)
NPI: 1245460237 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Arena from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Arena? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Arena

Dr. Elizabeth Arena is a surgical oncology physician in Los Angeles, CA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Arena performed 399 Medicare services across 277 unique beneficiaries.

Between the years covered by Open Payments, Dr. Arena received a total of $2,109 from 36 pharmaceutical and/or device companies across 63 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in surgical oncology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Arena is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice ▲ Top 30% volume in CA $2,109 industry payments

Medicare Practice Summary

Medicare Utilization ↗
399
Medicare services
Top 30% in CA for surgical oncology physician
277
Unique beneficiaries
$114
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~25 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
118 $106 $157
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
95 $74 $114
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
60 $35 $45
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
52 $140 $198
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
23 $64 $82
Partial removal of breast 17 $552 $891
Deep underarm lymph node biopsy or removal
A procedure to remove or sample deep lymph nodes located in the underarm area for examination.
17 $219 $593
Intraoperative lymph node imaging
Imaging performed during surgery to visualize lymph nodes.
17 $115 $185
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,109
Total received (2018-2024)
Avg $301/year across 7 years
Top 45% in CA for surgical oncology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
63
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,109 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$383
2023
$189
2022
$198
2021
$273
2020
$382
2019
$290
2018
$395

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
HISTOSONICS,INC.
$117
Novo Nordisk Inc
$48
Acera Surgical, Inc.
$34
Smith+Nephew, Inc.
$31
VERTEX PHARMACEUTICALS INCORPORATED
$29
Merck Sharp & Dohme LLC
$29
Takeda Pharmaceuticals U.S.A., Inc.
$28
Myriad Genetic Laboratories, Inc.
$26
Davol Inc.
$21
Paratek Pharmaceuticals, Inc.
$20
Top 3 companies account for 52.1% of 2024 payments
All-time payments by company (2018-2024) ›
Sientra, Inc.
$219
Intuitive Surgical, Inc.
$197
BAXTER HEALTHCARE
$170
HISTOSONICS,INC.
$117
ACELL, INC.
$112
Baxter Healthcare
$99
Myriad Genetic Laboratories, Inc.
$99
Takeda Pharmaceuticals U.S.A., Inc.
$97
Melinta Therapeutics, Inc.
$81
Becton, Dickinson and Company
$71
Ethicon US, LLC
$64
Allergan Inc.
$61
Merck Sharp & Dohme LLC
$54
Activ Surgical, Inc.
$54
Shire North American Group Inc
$48
Novo Nordisk Inc
$48
Smith+Nephew, Inc.
$47
TELA Bio, Inc.
$37
GE HEALTHCARE
$35
Acera Surgical, Inc.
$34
KARL STORZ Endoscopy-America
$34
VERTEX PHARMACEUTICALS INCORPORATED
$29
Elucent Medical
$29
Medline Industries, Inc.
$29
Allergan, Inc.
$28
Pacira Pharmaceuticals Incorporated
$25
Braintree Laboratories, Inc.
$22
Hologic Sales and Service, LLC
$21
Davol Inc.
$21
BOSTON SCIENTIFIC CORPORATION
$20
Paratek Pharmaceuticals, Inc.
$20
Merck Sharp & Dohme Corporation
$20
Integra LifeSciences Corporation
$20
Medtronic USA, Inc.
$19
Encision Inc
$15
GE HealthCare
$14
Top 3 companies account for 27.8% of all-time payments
Associated products mentioned in payments ›
AQUAMANTYS · ActivSight · BOWEL GRASPER · Baxdela · COLLAGENASE SANTYL · Da Vinci Surgical System · EXPAREL · Echelon Circular · FENESTRAT · FLOSEAL · GATTEX · GRAFIX PL · Hyalomatrix Wound Device · INSERT · KEYTRUDA · Localizer · MYRISK · NATRELLE · NUZYRA · OMNIGRAFT · Ovitex · Ozempic · PROGEL · Phasix Mesh · Restrata Wound Matrix · SEPRAFILM · SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT · SPYGLASS · STRATAFIX · STRATTICE · SUPREP BOWEL PREP · TISSEEL · Wegovy · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a surgical oncology physician in Los Angeles?
Compare surgical oncology physicians in the Los Angeles area by procedure volume, costs, and industry payment transparency.
Browse surgical oncology physicians nearby

Geographic Context

Surgical oncology physicians within 10 mi
93
Per 100K population
0.9
County median income
$87,760
Nearest hospital
CEDARS-SINAI MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Arena is a clinical cardiology specialist, with above-average Medicare volume (top 30% in CA), with low-engagement industry engagement, with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Arena experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Arena performed 118 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Arena receive payments from pharmaceutical companies?
Yes. Dr. Arena received a total of $2,109 from 36 companies across 63 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Arena's costs compare to other surgical oncology physicians in Los Angeles?
Dr. Arena's average Medicare payment per service is $114. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Arena) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →